Tunicamycin, an antibiotic that specifically blocks the synthesis of N-acetylglucosamine-lipid intermediates and thereby prevents glycosylation of glycoproteins, induced differentiation of both human (HL-60) and murine (MI) myeloid leukemia cell lines in culture. At 0.1-1.0 jg/ml, it induced differentiation of both A human myeloid leukemia cell line (HL-60) isolated from peripheral blood leukocytes of a patient with acute promyelocytic leukemia (1, 2), and a murine myeloid leukemia cell line (Ml) established from an SL strain mouse with spontaneous leukemia (3, 4) both can be induced to differentiate into mature granulocytes and macrophages by various inducers. These cell lines provide model systems for studies on mechanisms controlling myeloid cell differentiation. The inducers for differentiation include polar compounds such as dimethyl sulfoxide for both human (2) and murine myeloid leukemia cells (5) and glucocorticoids (6) and protein factors from various sources (4, 6-9) for murine myeloid leukemia cells. Lack of information on the precise functional properties of these inducers makes it difficult to understand the molecular mechanisms involved in expression of differentiated myeloid characteristics. For example, the cellular target site of dimethyl sulfoxide and the functional properties of the protein factors are still unknown.
A human myeloid leukemia cell line (HL-60) isolated from peripheral blood leukocytes of a patient with acute promyelocytic leukemia (1, 2), and a murine myeloid leukemia cell line (Ml) established from an SL strain mouse with spontaneous leukemia (3, 4) both can be induced to differentiate into mature granulocytes and macrophages by various inducers. These cell lines provide model systems for studies on mechanisms controlling myeloid cell differentiation. The inducers for differentiation include polar compounds such as dimethyl sulfoxide for both human (2) and murine myeloid leukemia cells (5) and glucocorticoids (6) and protein factors from various sources (4, (6) (7) (8) (9) for murine myeloid leukemia cells. Lack of information on the precise functional properties of these inducers makes it difficult to understand the molecular mechanisms involved in expression of differentiated myeloid characteristics. For example, the cellular target site of dimethyl sulfoxide and the functional properties of the protein factors are still unknown.
The studies reported here were designed to evaluate whether tunicamycin (10) (11) (12) , which specifically inhibits synthesis of N-acetylglucosaminyl pyrophosphoryl polyisoprenol leading to inhibition of protein glycosylation (13) (14) (15) (16) (17) (18) (19) (20) , could induce differentiation of Assay for Myeloid Differentiation. Phagocytic activity was measured as described by using polystyrene latex particles (9, 21) . The number of phagocytic cells was determined under a light microscope, phagocytic cells being defined as those containing five or more latex particles. Cells with Fc receptors were determined by measuring rosette formation with sheep erythrocytes coated with rabbit IgG, as described (21) . The number of rosette-forming cells with three or more erythrocytes per cell was determined under a light microscope. Lysozyme activity was determined in cell lysates and growth medium by a modification of the lysoplate method of Osserman and Lawler as described (21, 22) with heat-killed M. lysodeikticus as a substrate. Hen egg white lysozyme was used in each experiment as a standard, and 1 unit of lysozyme activity was defined as equivalent to 1 ,ug of hen egg white lysozyme.
Abbreviation: UDP-GIcNAc, UDP-N-acetylglucosamine. 409 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. Induction of differentiation of HL-60 cells by tunicamycin at 0.25 Mg/ml was inhibited by the simultaneous presence of excess amounts of UDP-N-acetylglucosamine (UDP-GlcNAc) in the medium (Fig. 2) In contrast, when Ml cells were cultured with tunicamycin at 0.25-1.0 MAg/ml, 40-50% of the cells had Fc receptors after 40 hr, representing more than a 6-fold increase in absolute numbers of cells with Fc-receptors (Fig. 3) (Fig. 4 A and B) . A decrease in the rate of glycoprotein synthesis, measured by incorporation of radioactive, glucosamine into trichloroacetic acid-insoluble materials was first detected 6 hr after beginning of culture with tunicamycin. At 12 hr, the rate of glycoprotein synthesis was decreased to < 20% of that in cells cultured without tunicamycin. It remained low for the following 36 hr. There was less than 25% inhibition of the rate of total protein synthesis during culture of the cells with tunicamycin. Concomitant with the decrease in glycoprotein synthesis, there were decreases in the rates of DNA and RNA synthesis, which were also first detected after 6 hr of culture with tunicamycin.
In Ml cells cultured without and with tunicamycin at 0.5
,gg/ml the rate of glycoprotein synthesis was decreased within 8 hr of culture of tunicamycin and continued to decrease (Fig.  4 C and D) . By 28 hr, it was decreased to 33% of the control values. In contrast, total protein synthesis measured by incorporation of radioactive leucine into acid insoluble material did not change until after 48 hr of culture with tunicamycin. The decrease in rate of glycoprotein synthesis was followed by inhibition of the rates of DNA and RNA synthesis. By 28 hr, the rate of DNA synthesis decreased to 35% and RNA synthesis was decreased to 70%. DISCUSSION Tunicamycin selectively inhibits the transfer of GlcNAc from UDP-GlcNAc to dolichol phosphate, thereby preventing the formation of GlcNAc pyrophosphoryl dolichol (14) (15) (16) (17) (18) (19) . Because GIcNAc-lipid has been shown to be the first intermediate involved in the assembly of the core regions of the oligosaccharides of many glycoproteins (11), inhibition of synthesis of this lipid prevents synthesis of the entire oligosaccharide, leading to inhibition of protein glycosylation. Because of 'its rather specific mode of action, tunicamycin has been used in studies on the biological roles of the oligosaccharide portions of glycoproteins (14) (15) (16) (17) (18) (19) .
Tunicamycin at 0.1-1.0,gg/ml of culture medium induced functional and morphological differentiation of both HL-60 and Ml cells in culture. After 20-48 hr of culture of HL-60 and Ml cells with tunicamycin, the percentage and the absolute numbers of phagocytic cells were greatly increased, and this increase was followed by the morphological changes characteristic of maturing myeloid cells. These results show that increased percentage of cells showing phagocytosis was not due to selective killing of undifferentiated cells by the antibiotic. The induction of phagocytosis by tunicamycin was effectively inhibited by simultaneous presence of UDP-GlcNAc, indicating that the antibiotic induces phagocytosis by blocking synthesis Tunicamycin did not induce lysozyme activity in either HL-60 or Ml cells. Lysozyme activity increased in the growth medium of HL-60 cells cultured with 1.25% dimethyl sulfoxide (unpublished observation). Lysozyme activity in Ml cells increases when the cells are cultured with various other inducers (5, 21, 23 ). Thus, it is possible that induction of lysozyme might require glycosylation of cellular proteins.
The early reduction of rate of glycoprotein synthesis was followed or accompanied by a decrease in DNA synthesis, with concomitant inhibition of cell growth. It is possible that inhibition of DNA synthesis was the result of induction of differentiation, because differentiated myeloid cells no longer have the capacity to proliferate. Alternatively, the inhibition of glycosylation of glycoprotein carriers (18) might lead to decreased transfer of metabolites across cell membranes, resulting in inhibition of DNA synthesis, and this inhibition of DNA synthesis might lead to expression of differentiated properties of myeloid cells. The present experiments did not distinguish between these two possibilities.
Myeloid leukemia cells in culture have been studied extensively to obtain information on the molecular mechanisms regulating myeloid differentiation (1, 8), but so far the mechanisms involved in inducing differentiation of these cells in culture by various inducers for differentiation of Ml cells, especially macromolecular inducers, are suggested to be on the plasma membranes (4, (6) (7) (8) 23 ). The present study clearly demonstrates that glycosylation of cellular proteins plays an 
